Reach Us +1-218-451-2974


Differentiating Parkinson’s Dementia From Other Types Of Dementia | 104267
ISSN: 2161-0460

Journal of Alzheimers Disease & Parkinsonism
Open Access

Like us on:

Our Group organises 3000+ Global Conferenceseries Events every year across USA, Europe & Asia with support from 1000 more scientific Societies and Publishes 700+ Open Access Journals which contains over 50000 eminent personalities, reputed scientists as editorial board members.

Open Access Journals gaining more Readers and Citations
700 Journals and 15,000,000 Readers Each Journal is getting 25,000+ Readers

This Readership is 10 times more when compared to other Subscription Journals (Source: Google Analytics)
Recommended Conferences
Google scholar citation report
Citations : 2275

Journal of Alzheimers Disease & Parkinsonism received 2275 citations as per google scholar report

Journal of Alzheimers Disease & Parkinsonism peer review process verified at publons
Indexed In
  • Index Copernicus
  • Google Scholar
  • Sherpa Romeo
  • Open J Gate
  • Genamics JournalSeek
  • Academic Keys
  • JournalTOCs
  • China National Knowledge Infrastructure (CNKI)
  • Electronic Journals Library
  • RefSeek
  • Hamdard University
  • OCLC- WorldCat
  • SWB online catalog
  • Virtual Library of Biology (vifabio)
  • Publons
  • Geneva Foundation for Medical Education and Research
  • Euro Pub
Share This Page

Differentiating Parkinson’s dementia from other types of dementia

5th International Conference on Parkinson’s disease and Movement Disorders

Rajendra D Badgaiyan

Icahn School of Medicine at Mt Sinai, USA

Keynote: J Alzheimers Dis Parkinsonism

DOI: 10.4172/2161-0460-C6-050

Diagnosis of Parkinson???s dementia is mostly clinical. However, there are many forms of demetia. Treatment approach of some forms of demetia is different from those of the Parkinson???s type. For example dementia due to Alzheimer???s disease are dependent on acetyl choline neurotransmission while Parkinson???s demetia is due to dysregulated dopamine neurotransmission. Because of subjective nature of clinical diagnosis, many patients are misdiagnosed with a different type of dementia, resulting in patients receiving wrong treatment. It is therefore important to have a diagnostic method that allows us to differentiate dopamine and acetyl choline dependent dementia. A novel neuroimaging technique that we recently developed could be useful in this context. The technique called single scan dynamic molecular imaging technique (SDMIT) uses positron emission tomography (PET) to detect, map and measure dopamine released acutely during cognitive or behavioral processing. It exploits the competition between a neurotransmitter and its receptor ligand for occupancy of the same receptor site. In this technique after patients are positioned in the PET camera, a radio-labeled neurotransmitter ligand is injected intravenously and the PET data acquisition started. These data are used by a receptor kinetic model to detect, map and measure neurotransmitter released dynamically in different brain areas. Patients are asked to perform a cognitive task while in the scanner and the amount of neurotransmitter released in different brain areas measured. By comparing it with the data acquired in age-matched healthy volunteers during performance of a similar task, it is possible to determine which neurotransmitter release is dysregulated in the patients and whether the dysregulation is responsible for clinical symptoms. Finding of a significant dysregulation of dopaminergic neurotransmission would indicate a diagnosis of Parkinson???s dementia while dysregulated acetyl choline neurotransmission would suggest dementia of Alzheimer???s type.

Rajendra D Badgaiyan, MD, is a psychiatrist and cognitive neuroscientist. He is Chairman of the Department of Psychiatry and Behavioral Sciences at Richmond University Medical Center, and Professor of Psychiatry at Icahn School of Medicine at Mount Sinai in New York. He received formal training in psychiatry, psychology, cognitive neuroscience, molecular imaging and neuroimaging. He was awarded the prestigious BK Anand National Research Prize in India and Solomon Award of Harvard Medical School. His research is focused on the study of neural and neurochemical mechanisms that control human brain functions. He developed the single scan dynamic molecular imaging technique (SDMIT) to detect, map, and measure neurotransmitters released acutely in the human brain during task performance. This technique is now used in laboratories all over the world. Using this technique, he studies dopaminergic control of human cognition and behavior. He is also interested in learning the nature of dysregulated dopamine neurotransmission in psychiatric and neuropsychiatric conditions. His research is funded by NIMH, NINDS, VA, and various foundations. Previously he served in the faculty of Harvard Medical School, SUNY Buffalo and University of Minnesota. He has published extensively in peer-reviewed journals.

E-mail: [email protected]